193 related articles for article (PubMed ID: 11430883)
1. Hyperactivity, neuromotor defects, and impaired learning and memory in a mouse model for metachromatic leukodystrophy.
D'Hooge R; Van Dam D; Franck F; Gieselmann V; De Deyn PP
Brain Res; 2001 Jul; 907(1-2):35-43. PubMed ID: 11430883
[TBL] [Abstract][Full Text] [Related]
2. Early signs of neurolipidosis-related behavioural alterations in a murine model of metachromatic leukodystrophy.
Stroobants S; Leroy T; Eckhardt M; Aerts JM; Berckmans D; D'Hooge R
Behav Brain Res; 2008 Jun; 189(2):306-16. PubMed ID: 18336930
[TBL] [Abstract][Full Text] [Related]
3. Telencephalic histopathology and changes in behavioural and neural plasticity in a murine model for metachromatic leukodystrophy.
Faldini E; Stroobants S; Lüllmann-Rauch R; Eckhardt M; Gieselmann V; Balschun D; D'Hooge R
Behav Brain Res; 2011 Sep; 222(2):309-14. PubMed ID: 21459117
[TBL] [Abstract][Full Text] [Related]
4. Neuromotor alterations and cerebellar deficits in aged arylsulfatase A-deficient transgenic mice.
D'Hooge R; Hartmann D; Manil J; Colin F; Gieselmann V; De Deyn PP
Neurosci Lett; 1999 Oct; 273(2):93-6. PubMed ID: 10505624
[TBL] [Abstract][Full Text] [Related]
5. Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.
Ramakrishnan H; Hedayati KK; Lüllmann-Rauch R; Wessig C; Fewou SN; Maier H; Goebel HH; Gieselmann V; Eckhardt M
J Neurosci; 2007 Aug; 27(35):9482-90. PubMed ID: 17728461
[TBL] [Abstract][Full Text] [Related]
6. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
[TBL] [Abstract][Full Text] [Related]
7. Reduced brain cholesterol content in arylsulfatase A-deficient mice.
Lütjohann D; Harzer K; Gieselmann V; Eckhardt M
Biochem Biophys Res Commun; 2006 Jun; 344(2):647-50. PubMed ID: 16630546
[TBL] [Abstract][Full Text] [Related]
8. Decline in brainstem auditory-evoked potentials coincides with loss of spiral ganglion cells in arylsulfatase A-deficient mice.
D'Hooge R; Coenen R; Gieselmann V; Lüllmann-Rauch R; De Deyn PP
Brain Res; 1999 Nov; 847(2):352-6. PubMed ID: 10575108
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
[TBL] [Abstract][Full Text] [Related]
11. Modest phenotypic improvements in ASA-deficient mice with only one UDP-galactose:ceramide-galactosyltransferase gene.
Franken S; Wittke D; Mansson JE; D'Hooge R; De Deyn PP; Lüllmann-Rauch R; Matzner U; Gieselmann V
Lipids Health Dis; 2006 Aug; 5():21. PubMed ID: 16893448
[TBL] [Abstract][Full Text] [Related]
12. Metachromatic leukodystrophy and nonverbal learning disability: neuropsychological and neuroradiological findings in heterozygous carriers.
Weber Byars AM; McKellop JM; Gyato K; Sullivan T; Franz DN
Child Neuropsychol; 2001 Mar; 7(1):54-8. PubMed ID: 11815881
[TBL] [Abstract][Full Text] [Related]
13. Probable metachromatic leukodystrophy/pseudodeficiency compound heterozygote at the arylsulfatase A locus with neurological and psychiatric symptomatology.
Hohenschutz C; Friedl W; Schlör KH; Waheed A; Conzelmann E; Sandhoff K; Propping P
Am J Med Genet; 1988 Sep; 31(1):169-75. PubMed ID: 2906225
[TBL] [Abstract][Full Text] [Related]
14. Metachromatic leukodystrophy: molecular genetics and an animal model.
Gieselmann V; Matzner U; Hess B; Lüllmann-Rauch R; Coenen R; Hartmann D; D'Hooge R; DeDeyn P; Nagels G
J Inherit Metab Dis; 1998 Aug; 21(5):564-74. PubMed ID: 9728336
[TBL] [Abstract][Full Text] [Related]
15. Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice.
Yaghootfam C; Gehrig B; Sylvester M; Gieselmann V; Matzner U
J Biol Chem; 2021 Sep; 297(3):101064. PubMed ID: 34375644
[TBL] [Abstract][Full Text] [Related]
16. Arylsulfatase A pseudodeficiency incidence in Turkey.
Emre S; Topçu M; Terzioğlu M; Renda Y
Turk J Pediatr; 2000; 42(2):115-7. PubMed ID: 10936976
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetics of metachromatic leukodystrophy.
Gieselmann V; Polten A; Kreysing J; Kappler J; Fluharty A; von Figura K
Dev Neurosci; 1991; 13(4-5):222-7. PubMed ID: 1687778
[TBL] [Abstract][Full Text] [Related]
18. The genetics of the aryl sulfatase A locus.
Schaap T; Zlotogora J; Elian E; Barak Y; Bach G
Am J Hum Genet; 1981 Jul; 33(4):531-9. PubMed ID: 6114634
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral administration of the competitive N-methyl-D-aspartate antagonist, CGP 40116, on passive avoidance, spatial learning, and neuromotor abilities in mice.
Hauben U; D'Hooge R; Soetens E; De Deyn PP
Brain Res Bull; 1999 Feb; 48(3):333-41. PubMed ID: 10229343
[TBL] [Abstract][Full Text] [Related]
20. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
